Showing results (61-70 of 281) with videos related to

Sort By:
Pageof 29
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative DisordersJorge J Castillo, Steven P Treon, Matthew S Davids
Cancer Treatment and Research|February 7, 2015
Biology, prognosis, and therapy of Waldenström MacroglobulinemiaJorge J Castillo, Irene M Ghobrial, Steven P Treon
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2022
When a Monoclonal Gammopathy Is Not Multiple MyelomaBenjamin Derman, Jorge J Castillo, Shayna Sarosiek, et al.
Expert Opinion on Investigational Drugs|February 4, 2012
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignanciesEric S Winer, Randall R Ingham, Jorge J Castillo
Clinical Advances in Hematology & Oncology : H&O|September 20, 2022
New treatment strategies for Waldenström macroglobulinemiaDavid F Moreno, Carlos Fernández de Larrea, Jorge J Castillo
American Journal of Hematology|May 9, 2012
No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studiesJorge J Castillo, Pradeep K Dhami, Stephanie Curry, et al.
Oncotargets and Therapy|March 5, 2014
Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignanciesJorge J Castillo, Meera Iyengar, Benjamin Kuritzky, et al.
Eneurologicalsci|September 23, 2024
Paraneoplastic myelitis associated with Waldenström macroglobulinemia responsive to treatment with ibrutinib - venetoclax: A case reportSathya Narasimhan, Kristin M Galetta, Jorge J Castillo, et al.
Leukemia Research|October 1, 2017
Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat diseaseThomas A Guerrero-Garcia, Renzo J Mogollon, Jorge J Castillo
Pageof 29